| Indian Journal of Medical Ethics | ||||||
![]() Home Current Issue Past Issues Support About IJME |
Working in two systems Anuradha Veeravalli andSrinivas Veeravalli discuss their experiences seeking treatment for their child Being interested in the possibility and implications of a different knowledge system, one of us (Anuradha Veeravalli) had read parts of Carakasamhita, an Ayurvedic text, in translation. Its understanding of health, disease, treatment and pharmacopia was fundamentally different. For instance, longevity was defined as that length of time during which one could continue to do one's dharma. This was in contrast to Allopathy's understanding that life should be prolonged at any cost whatever the damage to the patient (that one is pathologically defined as alive even if only as a vegetable) and to the community (both family and professional resources being commissioned for the purpose), provided there exist the technology and the medicine, and the finance to do so. Ayurveda seemed therefore to have a more sensible and complete understanding of the health of an individual and of treatment. The real question as to what one could and would do with this understanding arose when our daughter Dhriti was diagnosed as having epilepsy. The existence of Allopathy's infrastructure for immediate medical attention, and the fact that we were already in regular touch with a paediatrician, made it necessary for us to go ahead with Allopathy initially. Within this system it was necessary to get a second opinion. But alongside this, our inclination was to investigate the possibility of depending more and more on Ayurveda. The second opinion Contrary to common belief, and what Allopaths profess, the objective methods of testing and diagnosis did not bring about agreement about either diagnosis or treatment. The first controversy that came up was when we felt neither the paediatrician nor the neurologist understood the scope of their respective specialisations (and communicated with each other accordingly). The paediatrician read the tests as showing either demyelination or delayed myelination. He was more inclined to the latter and felt that there was not much cause for concern; he expected the growth to be complete and the problem to set itself right in the normal process of growing up. The neurologist on the other hand, diagnosed the problem as possibly medial temporal sclerosis. The paediatrician, who was conservative (not old-fashioned) in his approach and also willing to give more time to clinical examination, recommended Eptoin. The neurologist recommended Tegretol and immediately asked us to switch treatment as per his advice. Since for routine problems we had to be in touch with the paediatrician, and because we were already under his care, we requested the neurologist to discuss the case with our paediatrician. But there was no discussion. The neurologist merely restated his position to the paediatrician. This disagreement was not a reflection of either's assessment of the other's personal competence but of their professional competence. For example, reading the MRI or EEG of a growing child was different from reading those of an adult, according to the paediatrician; the variation in the MRIs and EEGs of normal children can be quite large and it is only extensive clinical experience in paediatrics that prepares you for understanding this. Therefore, neurologists who specialise in paediatrics are less equipped to read the MRI scans of children, and usually read too much into what otherwise could be characterised as normal variation. This we understood to be one of the pitfalls of over-specialisation. Apart from this, our impression was that the concerns of the paediatrician were larger and therefore more long-term than just gaining control of the immediate neurological problem. To enable us to make a decision, we had meanwhile met a third doctor, a neurologist, who would be able to give us time, an independent view as a friend and a professional, and who seemed more open to the possibility of using alternative medicine. What we seemed to have been looking for and missing was the dying (or shall we say 'dead'?) profession of the family/general physician, an informed and concerned mediator between patient and specialist. Why we chose Ayurveda The lack of consensus on the diagnosis amongst the Allopaths; the fear of side effects; and the understanding from our knowledge of Ayurveda as a system — is that its treatment was more positively in the direction of creating a healthy body rather than merely suppressing ; illness, of its understanding of the use of nutrition in treatment therefore, and not merely of medication — all these considerations made us think of consulting Ayurvedic doctors. The Allopaths have set the range of possibilities between something which would pass as the child grew up and something which could be degenerative (delayed myelination to demyelination), and were not willing to commit themselves. But what they did agree on was that if it was degenerative, allopathy did not have much to offer. Thus, Ayurveda was an option to be explored. But there were two angles, as it were, to this decision. First, even if it meant more trouble, physical, emotional and financial, we would rather trust our daughter to Ayurvedic medicine because in the long run it would have less harmful effects, unlike Eptoin, Gardenal orTegretol, which would have a bad impact on the general health of the child for life — an impact that Allopathy would count as a small price to pay for having dealt with the main problem. So, while for ourselves we may have taken the uncomplicated route with Allopathy and risked the side effects, we could not take the same chances with our child. Secondly, our intellectual convictions and committment were with Ayurveda, in its understanding of the human body and treatment as well as the style of life which emphasised discipline and restraint in every aspect of one's life. Although Ayurveda has, apparently, no objective forms of testing, the two Ayurvedic practitioners we met, independently, agreed on the prognosis (that the problem was not degenerative), on the diet (that food intake should be restricted and fat content should be cut down drastically), and on the duration of treatment. They said that there could be ups and downs but were emphatic that it was not a permanent condition and certainly not degenerative. The diet recommended here was diametrically opposed to the one recommended by the Allopaths, whose view was that since myelin is a fatty covering, to speed up myelination, a high fat diet would be useful. The Ayurvedic doctors were of the view that the main problem lay with her liver, that Dhriti was not able to assimilate fat, and that increasing the fat content in her diet would further overload her already weak liver, aggravate the problem and cause more seizures. Sure enough, once we started her on the Ayurvedic diet, we found, on more than one occasion, that any slight deviation could result in seizures. (But the Allopaths rejected this as merely coincidence and not indicative of any causal relationship.) No easy choices The Ayurvedic doctor predicted the course of the disease quite accurately and told us when the unconscious seizures would stop and also when the myelination was complete. After the last seizure he also told us that the nature of the ailment had changed and that we could expect more frequent minor twitchings in the left hand and leg which would last only a couple of minutes. Again, this was found to be the case. After about four seizure-free months, and after according to him the myelination was complete, he advised to reduce the dosage of Eptoin after. Comparing two systems The Allopath showed no curiosity about Ayurveda, even when predictions by Ayurvedic doctors seemed right. One may argue that every doctor doesn't have the time or inclination for research and experiment and that patients are not often willing to lend themselves to experimentation. However, as a group they do not seize any opportunity that comes their way. In a country rich with alternative traditions, some serious consideration should be given to Ayurveda. Research should be done taking into account of the entire perspective of Ayurveda, not merely to appropriate its drugs for Allopathic use. The onus for this lies more with the Allopathic system because it has the infrastructure, though it cannot happen without the cooperation and interest of the Ayurvedic doctor as well. Anuradha Veeravalli, Lecturer, Department of Philosophy, Hindu College, Delhi University, New Delhi 110007
|
|||||
|
| ||||||